Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens

被引：0
|
作者：
Sarah M. Kashanian
Noa G. Holtzman
Ciera L. Patzke
Jonathan Cornu
Alison Duffy
Madhurima Koka
Sandrine Niyongere
Vu H. Duong
Maria R. Baer
Jummai Apata
Farin Kamangar
Ashkan Emadi
机构：
[1] University of Maryland School of Medicine,Department of Medicine
[2] National Cancer Institute,Immune Deficiency Cellular Therapy Program, Center for Cancer Research
[3] National Institutes of Health,Greenebaum Comprehensive Cancer Center
[4] University of Maryland School of Medicine,Department of Pharmacy
[5] University of Maryland Medical Center,Department of Pathology
[6] University of Maryland School of Pharmacy,Center for Urban Health Disparities Research and Innovation
[7] University of Maryland School of Medicine,Department of Biology, School of Computer, Mathematical, and Natural Sciences
[8] Morgan State University,Department of Pharmacology
[9] Morgan State University,undefined
[10] University of Maryland School of Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 87卷
关键词：
Acute lymphoblastic leukemia; Pegylated-asparaginase; Pegaspargase; ALL; Venous thromboembolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 826
页数：9
相关论文
共 50 条
  • [21] Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors
    Luong, Nhiem V.
    Kroll, Michael H.
    Vu, Khanh
    THROMBOSIS RESEARCH, 2017, 156 : 14 - 19
  • [22] Venous Thromboembolism in Adolescents and Young Adults with Acute Lymphoblastic Leukemia Treated on a Pediatric-Inspired Regimen
    Raman, Hari S.
    Shimony, Shai
    Valtis, Yannis K.
    Flamand, Yael
    Place, Andrew E.
    Silverman, Lewis B.
    Sallan, Stephen E.
    Vrooman, Lynda M.
    Brunner, Andrew M.
    Neuberg, Donna S.
    Galinsky, Ilene
    Garcia, Jacqueline S.
    Winer, Eric S.
    Wadleigh, Martha
    Stone, Richard M.
    Connors, Jean M.
    DeAngelo, Daniel J.
    Luskin, Marlise R.
    BLOOD, 2023, 142
  • [23] Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen
    Shimony, Shai
    Raman, Hari S.
    Flamand, Yael
    Keating, Julia
    Paolino, Jonathan D.
    Valtis, Yannis K.
    Place, Andrew E.
    Silverman, Lewis B.
    Sallan, Stephen E.
    Vrooman, Lynda M.
    Brunner, Andrew M.
    Neuberg, Donna S.
    Galinsky, Ilene
    Garcia, Jacqueline S.
    Winer, Eric S.
    Wadleigh, Martha
    Stone, Richard M.
    Connors, Jean M.
    DeAngelo, Daniel J.
    Luskin, Marlise R.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [24] Symptomatic venous thromboembolism in acute leukemia.: Incidence, risk factors, and impact on prognosis
    Ziegler, S
    Sperr, WR
    Knöbl, P
    Lehr, S
    Weltermann, A
    Jäger, U
    Valent, P
    Lechner, K
    THROMBOSIS RESEARCH, 2005, 115 (1-2) : 59 - 64
  • [25] Evaluation of Residual Disease Positivity Rates in Adult Acute Lymphoblastic Leukemia Patients Treated with Asparaginase Versus Non-Asparaginase Containing Regimens
    Cerdena, Sebastian
    Mackey, Melissa C.
    Kuchibhatla, Maragatha
    Rizzieri, David A.
    Moorman, Meredith T.
    BLOOD, 2017, 130
  • [26] Pegylated E. coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi availability
    Verma, Anupam
    Chen, Karin
    Johnsen, Jacob
    Barnette, Phillip
    BLOOD, 2018, 132
  • [27] Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis
    Klaassen, Irene L. M.
    Lauw, Mandy N.
    Fiocco, Marta
    van der Sluis, Inge M.
    Pieters, Rob
    Middeldorp, Saskia
    van de Wetering, Marianne D.
    de Groot-Kruseman, Hester A.
    van Ommen, C. Heleen
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 234 - 241
  • [28] PEGylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability
    Verma, Anupam
    Chen, Karin
    Bender, Cynthia
    Gorney, Nathan
    Leonard, Whitney
    Barnette, Phillip
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (05) : 277 - 286
  • [29] Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
    Vrooman, Lynda M.
    Kirov, Ivan I.
    Dreyer, ZoAnn E.
    Kelly, Michael
    Hijiya, Nobuko
    Brown, Patrick
    Drachtman, Richard A.
    Messinger, Yoav H.
    Ritchey, A. Kim
    Hale, Gregory A.
    Maloney, Kelly
    Lu, Yuan
    Plourde, Paul V.
    Silverman, Lewis B.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 228 - 233
  • [30] Cost-Effectiveness Of Antithrombin Repletion In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy; A Single Center Experience
    McCullough, Kristen B.
    Barreto, Jason N.
    Peskey, Candy S.
    Gastineau, Dennis A.
    Elliott, Michelle
    Gangat, Naseema
    Patnaik, Mrinal M.
    Litzow, Mark R.
    Hogan, William J.
    BLOOD, 2013, 122 (21)
12345